Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:e19
Published online before print April 10, 2003, doi: 10.1161/01.STR.0000069436.07686.CA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/5/e19    most recent
01.STR.0000069436.07686.CAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cucchiara, B.
Right arrow Articles by Kasner, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cucchiara, B.
Right arrow Articles by Kasner, S. E.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Blood Thinners
Hazardous Substances DB
*HEPARIN

(Stroke. 2003;34:e19.)
© 2003 American Heart Association, Inc.


Letters to the Editor

Danger of Treatment Protocols

Brett Cucchiara, MD; Steven Messé, MD Scott E. Kasner, MD

Department of Neurology, Comprehensive Stroke Center, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

A recent AHA Scientific Statement on medication errors in acute cardiovascular care suggested that streamlined protocols and standardized order forms may be useful in reducing medical errors.1 We would like to draw attention to a potential danger of such measures, namely the erroneous application of tPA treatment protocols for acute myocardial infarction (MI) to patients with acute stroke. We report a case of such a misapplication that possibly contributed to development of an intracerebral hemorrhage (ICH).

A 68-year-old man with a history of aortic valve replacement presented to an emergency department 90 minutes after onset of aphasia and right hemiparesis. Initial head CT and laboratory studies were normal. The patient was treated with intravenous tPA according to the NINDS stroke thrombolysis protocol.2 The treating neurologist wrote orders consistent with this protocol, including avoidance of antithrombotic or anticoagulant therapies for 24 hours. Unfortunately, the nursing staff caring for the patient erroneously implemented the hospital’s standardized prewritten acute MI thrombolysis protocol, and the patient was given a bolus of intravenous heparin followed by a maintenance infusion. One hour later the error was noted and heparin was discontinued. A repeat head CT was immediately performed and showed a new left thalamic ICH as well as early signs of left temporal-parietal infarction. Over the next 24 hours, the patient’s right-sided weakness improved significantly, although he remained markedly aphasic. The patient was transferred to our institution where subsequent evaluation revealed a high-grade left carotid stenosis. Follow-up head CT showed a stable left . . . [Full Text of this Article]